Of note, androgen was recently shown to reduce sensitivity of AR-positive bladder cancer cells to doxorubicin [23], an anthracycline anti-tumor antibiotic often used for intravesical chemotherapy to prevent tumor recurrence. The gene discussed is AR; the disease is urinary bladder cancer.